Hide Images            Print Print            Close window
Ad-hoc News
07/14/2010 Ad-hoc: Biotest AG: Preliminary Results
02/16/2010 Ad-hoc: Biotest AG: Biotest significantly increases sales, EBIT above the high level of last year
10/23/2009 Ad-hoc: Biotest AG: Biotest agrees to sell its Medical Diagnostics business to Bio-Rad
08/12/2009 Ad-hoc: Biotest AG: Ad-hoc RELEASE; Announcement according to § 15 Sec. 1 Securities Trading Act (WpHG)
05/07/2009 Ad-hoc: Biotest AG: Press Release- Biotest AG: 'Biotest sales and EBIT growth in first quarter; extension of credit facility'
02/04/2009 Ad-hoc: Biotest AG: Biotest records significant growth in sales and earnings, Majority shareholder terminates discussion about shares' sale
10/28/2008 Ad-hoc: Biotest AG: Majority shareholder of Biotest AG in discussions about selling shares
07/18/2008 Ad-hoc: Biotest AG: strong first half year, profit target raised
05/27/2008 Ad-hoc: Biotest AG: Forecast for turnover and profit raised
02/22/2008 Ad-hoc: Biotest AG: Biotest marked increase in sales and earnings recorded in 2007
09/21/2007 Ad-hoc: Biotest AG:Biotest successfully concludes 10% capital increase
09/11/2007 Ad-hoc: Biotest AG:Biotest AG acquires plasma protein unit from Nabi Biopharmaceuticals Corp.
07/19/2007 Ad-hoc: Biotest AG: Biotest significantly increases sales and earnings target for 2007
02/14/2007 Ad-hoc: Biotest AG: Increase in sales and earnings in financial year 2006 higher than expected
05/03/2006 Ad-hoc: Biotest AG:Biotest and Sanquin plan a strategic alliance in plasma products
10/10/2005 Ad hoc news: Biotest fixes subscription price
09/06/2005 Ad hoc news: Biotest AG increases capital stock by up to EUR 3.9 million
06/30/2005 Ad hoc news: Biotest AG increases capital stock by 2.92 million Euro
03/24/2005 Ad hoc news: Change of the Supervisory Board
03/16/2005 Ad hoc news: Excellent preliminary result: Biotest achieves group profit of EUR 5.0 million in 2004
04/25/2003 Ad hoc news: Biotest: Positive operating profit before special items from core activities
03/11/2003 Ad hoc news: Notice according to §15 WPHG (German Security Trading Act) Biotest AG's year-end result for 2002 depressed by restructuring expenditure despite sales increase
Ad-hoc News

Listed companies are obliged by law to publish without delay news of all company occurences that could influence the share price significantly (section 15 of the German securities Trading Act).

05/08/2012 Ad-hoc: Biotest AG: Preliminary investigation by public prosecution - Company rejects suspicions
02/20/2012 Ad-hoc: Biotest AG: Slight increase in sales of 2.3% despite difficult market environment
06/21/2011 Ad-hoc: Biotest AG: Agreement with Abbott
04/28/2011 Ad-hoc: Biotest AG: Ad hoc ANNOUNCEMENT
03/22/2011 Ad-hoc: Biotest AG: Ad-hoc RELEASE Announcement according to § 15 Sec. 1 Securities Trading Act (WpHG)
02/15/2011 Ad-hoc: Biotest AG: Increase in sales of more than 5%
07/14/2010 Ad-hoc: Biotest AG: Preliminary Results
02/16/2010 Ad-hoc: Biotest AG: Biotest significantly increases sales, EBIT above the high level of last year
10/23/2009 Ad-hoc: Biotest AG: Biotest agrees to sell its Medical Diagnostics business to Bio-Rad
08/12/2009 Ad-hoc: Biotest AG: Ad-hoc RELEASE; Announcement according to § 15 Sec. 1 Securities Trading Act (WpHG)
05/07/2009 Ad-hoc: Biotest AG: Press Release- Biotest AG: 'Biotest sales and EBIT growth in first quarter; extension of credit facility'
02/04/2009 Ad-hoc: Biotest AG: Biotest records significant growth in sales and earnings, Majority shareholder terminates discussion about shares' sale
10/28/2008 Ad-hoc: Biotest AG: Majority shareholder of Biotest AG in discussions about selling shares
07/18/2008 Ad-hoc: Biotest AG: strong first half year, profit target raised
05/27/2008 Ad-hoc: Biotest AG: Forecast for turnover and profit raised
02/22/2008 Ad-hoc: Biotest AG: Biotest marked increase in sales and earnings recorded in 2007
09/21/2007 Ad-hoc: Biotest AG:Biotest successfully concludes 10% capital increase
09/11/2007 Ad-hoc: Biotest AG:Biotest AG acquires plasma protein unit from Nabi Biopharmaceuticals Corp.
07/19/2007 Ad-hoc: Biotest AG: Biotest significantly increases sales and earnings target for 2007
02/14/2007 Ad-hoc: Biotest AG: Increase in sales and earnings in financial year 2006 higher than expected
05/03/2006 Ad-hoc: Biotest AG:Biotest and Sanquin plan a strategic alliance in plasma products
10/10/2005 Ad hoc news: Biotest fixes subscription price
09/06/2005 Ad hoc news: Biotest AG increases capital stock by up to EUR 3.9 million
06/30/2005 Ad hoc news: Biotest AG increases capital stock by 2.92 million Euro
03/24/2005 Ad hoc news: Change of the Supervisory Board
03/16/2005 Ad hoc news: Excellent preliminary result: Biotest achieves group profit of EUR 5.0 million in 2004
04/25/2003 Ad hoc news: Biotest: Positive operating profit before special items from core activities
03/11/2003 Ad hoc news: Notice according to §15 WPHG (German Security Trading Act) Biotest AG's year-end result for 2002 depressed by restructuring expenditure despite sales increase